These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25027696)

  • 1. [In vitro susceptibility of rapidly growing mycobacteria biofilms against different antimicrobials].
    Muñoz-Egea MC; García-Pedrazuela M; Esteban J
    Enferm Infecc Microbiol Clin; 2015 Feb; 33(2):136-7. PubMed ID: 25027696
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of ciprofloxacin in the ultrastructure and development of biofilms formed by rapidly growing mycobacteria.
    Muñoz-Egea MC; García-Pedrazuela M; Mahillo I; Esteban J
    BMC Microbiol; 2015 Feb; 15():18. PubMed ID: 25887547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiofilm effect of antimicrobials used in the therapy of mycobacteriosis.
    Flores VD; Siqueira FD; Mizdal CR; Bonez PC; Agertt VA; Stefanello ST; Rossi GG; Campos MM
    Microb Pathog; 2016 Oct; 99():229-235. PubMed ID: 27554273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial activities of dendritic amphiphiles against nontuberculous mycobacteria.
    Falkinham JO; Macri RV; Maisuria BB; Actis ML; Sugandhi EW; Williams AA; Snyder AV; Jackson FR; Poppe MA; Chen L; Ganesh K; Gandour RD
    Tuberculosis (Edinb); 2012 Mar; 92(2):173-81. PubMed ID: 22209468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of drug susceptibility in rapidly growing mycobacteria by resazurin broth microdilution assay.
    Castilho AL; Caleffi-Ferracioli KR; Canezin PH; Dias Siqueira VL; de Lima Scodro RB; Cardoso RF
    J Microbiol Methods; 2015 Apr; 111():119-21. PubMed ID: 25683207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of carvacrol against resistant rapidly growing mycobacteria in the planktonic and biofilm growth mode.
    Marini E; Di Giulio M; Ginestra G; Magi G; Di Lodovico S; Marino A; Facinelli B; Cellini L; Nostro A
    PLoS One; 2019; 14(7):e0219038. PubMed ID: 31260476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiofilm activity of nanoemulsions of Cymbopogon flexuosus against rapidly growing mycobacteria.
    Rossi GG; Guterres KB; Bonez PC; da Silva Gundel S; Aggertt VA; Siqueira FS; Ourique AF; Wagnerd R; Klein B; Santos RCV; de Campos MMA
    Microb Pathog; 2017 Dec; 113():335-341. PubMed ID: 29122674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring how structural changes to new Licarin A derivatives effects their bioactive properties against rapid growing mycobacteria and biofilm formation.
    Alvarenga DJ; Matias LMF; Oliveira LM; Leão LPMO; Hawkes JA; Raimundo BVB; Castro LFD; Campos MMA; Siqueira FDS; Santos TD; Carvalho DT
    Microb Pathog; 2020 Jul; 144():104203. PubMed ID: 32304794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid susceptibility testing for slowly growing nontuberculous mycobacteria using a colorimetric microbial viability assay based on the reduction of water-soluble tetrazolium WST-1.
    Tsukatani T; Suenaga H; Shiga M; Ikegami T; Ishiyama M; Ezoe T; Matsumoto K
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):1965-73. PubMed ID: 26173690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.
    Gitti Z; Mantadakis E; Maraki S; Samonis G
    Future Microbiol; 2011 Sep; 6(9):1099-109. PubMed ID: 21958147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyclonality among clinical strains of non-pigmented rapidly growing mycobacteria: phenotypic and genotypic differences and their potential implications.
    García-Pedrazuela M; Frutos JM; Muñoz-Egea MC; Alcaide F; Tórtola T; Vitoria A; Cortés P; Esteban J
    Clin Microbiol Infect; 2015 Apr; 21(4):348.e1-4. PubMed ID: 25596780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic susceptibility of Mycobacterium marinum.
    Forsgren A
    Scand J Infect Dis; 1993; 25(6):779-82. PubMed ID: 8052821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium kansasii.
    Fabry W; Schmid EN; Ansorg R
    Chemotherapy; 1995; 41(4):247-52. PubMed ID: 7555204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nontuberculous Mycobacteria: Epidemiologic, Mycobacteriologic, and Clinical Aspects.
    Mirsaeidi M; Farnia P; Sadikot R; Hsueh PR; Aliberti S
    Biomed Res Int; 2015; 2015():523697. PubMed ID: 26161405
    [No Abstract]   [Full Text] [Related]  

  • 16. Time-kill kinetics of antibiotics active against rapidly growing mycobacteria.
    Ferro BE; van Ingen J; Wattenberg M; van Soolingen D; Mouton JW
    J Antimicrob Chemother; 2015 Mar; 70(3):811-7. PubMed ID: 25344808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J; Kuijper EJ
    Future Microbiol; 2014; 9(9):1095-110. PubMed ID: 25340838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic drug susceptibility testing of rapid growing mycobacteria and the issue of antibiotic stability.
    Wetzstein N; Wichelhaus TA
    Diagn Microbiol Infect Dis; 2022 Jan; 102(1):115555. PubMed ID: 34678713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Efficacy of Novel Oxazolidinone Analogues against Nontuberculous Mycobacteria In Vitro.
    Zhao W; Jiang Y; Bao P; Li Y; Tang L; Zhou Y; Zhao Y
    Jpn J Infect Dis; 2015; 68(6):520-2. PubMed ID: 25971324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapidly growing mycobacterial bloodstream infections.
    El Helou G; Viola GM; Hachem R; Han XY; Raad II
    Lancet Infect Dis; 2013 Feb; 13(2):166-74. PubMed ID: 23347634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.